This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Marbán, E. Search for Related Content PubMed Articles by Marbán, E.

(Circulation Research. 2003;93:793.)
© 2003 American Heart Association, Inc.

Editorials

New Associate Editor Appointed to Circulation Research

Eduardo Marbán

From the Editor in Chief, Circulation Research.

Correspondence to Eduardo Marbán, MD, PhD, Editor in Chief, Circulation Research, 2700 Lighthouse Point East, Suite 230, Baltimore, MD 21224. E-mail circulation.research@circresearch.com

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Circulation Research has experienced an overall increase in yearly manuscript submissions of 33% since we took over the editorship of the journal in July 1999, including a significant 19.8% increase in submissions in 2003 to date (January to September) over the same time frame in 2002. Given the steadily increasing volumes of manuscripts submitted, the Editors felt it wise to recruit an eleventh Associate Editor.

Accordingly, I am pleased to announce that Dr Kathy Griendling has agreed to serve as a new Associate Editor for Circulation Research. She received her PhD from Johns Hopkins University and completed a fellowship in Physiology at the University of Pennsylvania and a research fellowship in Cardiology at Harvard University. In 1986, she became an Instructor in Medicine at Brigham and Women’s Hospital. She moved to Emory University in 1988 and is now Professor of Medicine in Cardiology and a Fellow of the American Heart Association. Dr Griendling’s research delineates the molecular mechanisms responsible for regulation of angiotensin II–induced vascular hypertrophy. She is particularly interested in the role of reactive oxygen species derived from the NADPH oxidase in modulating these events and has published more than 130 articles in this area.

Dr Griendling has been continually funded by the National Institutes of Health since 1987 and has received several grants from the American Heart Association. In addition to having served on the Circulation Research editorial board for many years, Dr Griendling serves on the editorial boards of Hypertension, Arteriosclerosis, Thrombosis, and Vascular Biology. . . [Full Text of this Article]